1 – 10 of 37
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma
(
- Contribution to journal › Article
-
Mark
Prolonged and intense neuroinflammation after severe traumatic brain injury assessed by cerebral microdialysis with 300 kDa membranes
(
- Contribution to journal › Article
-
Mark
Low Morbidity and Mortality in Children with Severe Traumatic Brain Injury Treated According to the Lund Concept : A Population-Based Study
(
- Contribution to journal › Article
- 2022
-
Mark
Intratumoral administration of the antisecretory peptide AF16 cures murine gliomas and modulates macrophage functions
(
- Contribution to journal › Article
- 2020
-
Mark
Antisecretory Factor May Reduce ICP in Severe TBI—A Case Series
(
- Contribution to journal › Article
-
Mark
Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas
(
- Contribution to journal › Article
- 2019
-
Mark
The effect of locally delivered cisplatin is dependent on an intact immune function in an experimental glioma model
(
- Contribution to journal › Article
- 2017
-
Mark
Radiotherapy induces an immediate inflammatory reaction in malignant glioma : a clinical microdialysis study
(
- Contribution to journal › Article
-
Mark
Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation
(
- Contribution to journal › Article
- 2016
-
Mark
Preoperative systemic levels of VEGFA, IL-7, IL-17A, and TNF-β delineate two distinct groups of children with brain tumors
(
- Contribution to journal › Article